Cell Therapeutics, Inc.'s Pixantrone Overview in Non-Hodgkin’s Lymphoma to be Presented at 2009 Pan Pacific Lymphoma Conference

SEATTLE, June 16 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) today announced that Richard Van der Jagt, M.D. of Ottawa Hospital will be presenting an overview of pixantrone clinical studies in non-Hodgkin’s lymphoma at the 2009 Pan Pacific Lymphoma Conference on Monday, June 22, 2009. The conference will be held from June 22-26, 2009 at the Fairmont Orchid hotel on the Big Island of Hawaii.

CONTACT: Dan Eramian, +1-206-272-4343, Cell, +1-206-854-1200,
deramian@ctiseattle.com, or Investors, Ed Bell, +1-206-282-7100, or Lindsey
Jesch Logan, +1-206-272-4347, or fax, +1-206-272-4434,
invest@ctiseattle.com, all of Cell Therapeutics, Inc.

Web site: http://www.celltherapeutics.com/

MORE ON THIS TOPIC